|  Help  |  About  |  Contact Us

Comment :

Type  MGI:General Description  treatment with Hrh4 antagonist (JNJ 10191584) during ovalbumin challenge results in decreased total bronchoalveolar lavage cell numbers (54%) and eosinophils (75%)